[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-zfsw":3},{"head":4,"company":39,"invest":44,"children":45,"shops":46,"category":47,"sameIndustry":5,"rid":6},{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"brandId":6,"brandLogo":7,"brandImage":5,"brandName":8,"webName":9,"balias":5,"enterId":10,"mainindustry":11,"industry":5,"brandType":5,"brandHonor":5,"brandTel":12,"establishdate":13,"brandBirth":14,"cityarea":5,"brandWebsite":5,"brandSobp":5,"brandVisit":5,"totalVisits":15,"status":16,"isDeleted":16,"comment":5,"remark":5,"logoExistStatus":17,"imageExistStatus":17,"industryId":5,"industryRanking":5,"score":5,"enterName":18,"mallShopList":19,"brandSummary":20,"likes":5,"unlikes":5,"follow":5,"pagetitle":21,"pagekeywords":22,"pagedesc":23,"brandContent":24,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":12,"enterWebsite":36,"business":37,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"regtrademark":5},null,"22208","\u002Fprofile\u002Fupload\u002F2025\u002F01\u002F25\u002F6d0c9ebb3a463c5f471202f3beb1b136.gif","智飞生物ZFSW","zfsw",19444,8602,"023-86358685","2002年","重庆市",836,0,"1","重庆智飞生物制品股份有限公司",[],"智飞生物成立于2002年，是一家集疫苗、生物制品研发、生产、销售、推广、配送及进出口为一体的国际化、全产业链生物高科技上市公司（股票代码：300122），以人用疫苗为主营产品，构建了流脑疫苗、结核产品、肺炎疫苗、肠道疫苗、多联疫苗等八大产品矩阵，并，形成了研发、市场相互促进、互相转化的良好循环机制。","智飞生物ZFSW简介-智飞疫苗-品牌之家","智飞生物新冠疫苗,智飞重组蛋白疫苗,智飞重组结核杆菌融合蛋白,智飞流感嗜血杆菌结合疫苗,智飞肺炎球菌多糖疫苗","智飞生物ZFSW品牌简介，品牌之家为你介绍重庆智飞生物制品股份有限公司旗下智飞生物ZFSW品牌信息，包括品牌介绍、联系方式、主营产品、最新评论、点赞数量等，告诉你智飞疫苗怎么样，致力于帮助你了解智飞生物ZFSW真实有效的品牌相关信息。","智飞生物2002年投入生物制品行业，专注于疫苗防御领域的开发，目前已发展成为集疫苗、生物制品的研发、生产、推广、销售、配送及进出口为一体的生物高科技企业\n\n重庆智飞生物制品股份有限公司2002年投入生物制品行业，2021年上半年实现营业收入132亿元，现有资产239亿元，智飞员工4500余人。2010年9月在深交所挂牌上市（股票代码：300122），旗下五家全资子公司及两家参股公司，其中北京智飞绿竹生物制药有限公司（简称“智飞绿竹”）及安徽智飞龙科马生物制药有限公司（简称“智飞龙科马”）为高新技术企业。\n\n智飞生物系一家集疫苗、生物制品的研发、生产、推广、销售、配送及进出口为一体的生物高科技企业，主营的人用疫苗为国家七大战略性新兴产业，发展前景广阔。现在售产品包括重组新型冠状病毒疫苗（CHO细胞）（智克威得®）、重组结核杆菌融合蛋白(EC，宜卡®）、ACYW135群脑膜炎球菌多糖疫苗（盟威克®）、A群C群脑膜炎球菌多糖结合疫苗（盟纳康®）、b型流感嗜血杆菌结合疫苗（喜菲贝®）、注射用母牛分枝杆菌（微卡®）等自主产品及统一销售默沙东的四价人乳头瘤病毒疫苗（酿酒酵母）、九价人乳头瘤病毒疫苗（酿酒酵母）、口服五价重配轮状病毒减毒活疫苗（Vero细胞）、23价肺炎球菌多糖疫苗、甲型肝炎灭活疫苗（人二倍体细胞）等所有进口疫苗。\n\n公司通过“技术+市场”的双轮驱动模式，形成了市场、研发相互促进、互相转化的良好循环机制，加速了疫苗产品从研发到实现市场价值转换的进程，逐步形成了独具特色、领先市场的核心竞争力。\n\n公司组建了素质过硬的专家研发团队，注重研发技术的引进和开发，先后参与了科技部863计划“现代医学技术”项目、科技部重大新药创制、国家新药创制重大专项等20余项重大项目。公司自主在研项目26项包括正在申请文号的、获得临床批件及临床前的项目，产品主要涉及预防肺结核、新冠、流脑、肺炎、流感、狂犬病、诺如病毒感染等人用疫苗项目，研发产品梯次结构清晰，层次丰富。同时，公司根据战略发展需要布局大生物领域，进入治疗性生物制品行业。此外，公司构建了覆盖全面、深入终端的服务网络，为全国31个省、自治区、直辖市，30000余个基层卫生服务点（乡镇接种点、社区门诊）提供持续、快捷、全面的优质服务。","重庆市江北区庆云路1号50层","91500000203049808L","股份有限公司(上市、自然人投资或控股)","蒋仁生","1995-07-20","重庆市市场监督管理局","-","2024-07-12","239,378.9747万(元)","40,000万(元)","批发生物制品；境外疫苗代理进口及销售；生物技术研究开发、技术咨询服务；货物及技术进出口；仓储服务（不含危险品）；生物制品市场推广宣传服务；普通货运、货物专用运输（冷藏保鲜）；国内货物运输代理。（依法须经批准的项目，经相关部门批准后方可开展经营活动）","www.zhifeishengwu.com","批发业","office1@zhifeishengwu.cn",{"enterId":40,"enterName":18,"province":5,"city":5,"area":5,"detailaddress":25,"unifiedscc":26,"enterType":27,"enterLegalperson":28,"enterStablishdate":29,"regauthority":30,"licenseValidity":31,"approvaldate":32,"regcapital":33,"incapital":34,"businessscope":35,"ownBrand":5,"enterTelphone":12,"enterWebsite":36,"business":37,"performance":41,"socialSecurity":42,"registrationNumber":43,"enterQq":5,"enterMail":38,"bindUser":5,"enterMployeenum":5,"regcapitalunit":5,"abnormal":5,"yeartax":5,"status":16,"regtrademark":5,"remark":5},"19444","开业","3877人","500105000065802",{"createTime":5,"updateTime":5,"createBy":5,"updateBy":5,"id":5,"brandId":5,"brandName":5,"busmodel":5,"franchiseFund":5,"totalStores":5,"devmodel":5,"franchiseIndustry":5,"investmenttel":5,"suitablePeople":5,"state":5},[],[],[48,64],{"createTime":49,"updateTime":50,"createBy":5,"updateBy":5,"industryId":51,"webId":5,"industryName":52,"industryAlias":5,"industryIcon":5,"industryTrans":53,"pageTitle":54,"pageDesc":55,"pageKeywords":56,"mainTitle":57,"pageSubtitle":58,"indSummary":59,"industryLevel":60,"parentId":61,"parentName":5,"sortOrder":62,"status":16,"classifyVisit":5,"totalVisits":63,"searchName":5,"starLevel":5,"limit":5},"2000-01-01 00:00:00","2026-06-16 16:50:00","8602","疫苗","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002Fc5a4873d1129759bfb754af8c30ad9d2.png","十大大型疫苗公司排行榜-人用疫苗公司有哪些-ZGALL品牌榜","2026年疫苗行业十大品牌权威发布！疫苗排行榜前十名品牌有中国生物、默沙东、辉瑞、葛兰素史克、赛诺菲、智飞生物、沃森、万泰疫苗、康泰、华兰。疫苗10大品牌由品牌中国重磅推出，旨在呈现行业领域标杆品牌，展现行业优秀企业实力，帮助你了解大型疫苗公司有哪些品牌。","大型疫苗公司有哪些,大型疫苗公司排名,疫苗种类有几种厂家,中国人用疫苗企业有多少,大型疫苗公司排名前十","疫苗品牌排行榜","2026人用疫苗企业排行，大型疫苗公司排行榜，疫苗厂家有哪些","疫苗什么牌子好？品牌TOP榜权威发布2026年疫苗十大品牌名录；居前十的有：中国生物CNBG、MSD默沙东、pfizer辉瑞、GSK葛兰素史克、赛诺菲巴斯德、智飞生物ZFSW、沃森生物WALVAX、万泰疫苗INNOVAX、康泰生物、华兰疫苗等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",3,1411,99,395,{"createTime":49,"updateTime":50,"createBy":5,"updateBy":5,"industryId":65,"webId":5,"industryName":66,"industryAlias":5,"industryIcon":5,"industryTrans":67,"pageTitle":68,"pageDesc":69,"pageKeywords":70,"mainTitle":71,"pageSubtitle":72,"indSummary":73,"industryLevel":60,"parentId":61,"parentName":5,"sortOrder":62,"status":16,"classifyVisit":5,"totalVisits":74,"searchName":5,"starLevel":5,"limit":5},"10006","生物科技","\u002Fprofile\u002Fupload\u002F2023\u002F11\u002F08\u002F19f46e89d8cd077b73c7adb33bb2b59f.png","生物科技公司十大排行榜-国内知名生物科技公司有哪些-ZGALL品牌榜","2026年十大生物科技公司排行榜最新发布，生物科技公司十大排行榜前十名有中国生物、中国生物制药、百济神州、恒瑞、豪森药业、百利天恒、康方、复星医药、石药、信达。生物科技十大品牌排行榜由品牌研究部门收集整理大数据分析研究得出，帮助你了解中国生物科技公司有哪些。","生物科技公司排名前十有哪些,中国生物科技公司排名前十,生物科技有限公司排名,中国生物科技公司排名,全国生物科技公司排名","生物科技品牌排行榜","2026生物科技公司，生物制药公司排行榜，国内生物医药科技公司有哪些","生物科技哪个好？品牌TOP榜权威发布2026年生物科技名录；居前十的有：中国生物CNBG、中国生物制药、百济神州BeiGene、恒瑞医药、豪森药业、百利天恒、康方Akesobio、复星医药、石药CSPC、信达生物Innovent等，【行业品牌名录】基于大数据与人工智能技术，整合300+国际权威榜单及企业申报数据，通过算法分析市场占有率、创新力等12项指标，并解析超百万条舆情信息，采用加权模型（算法60%+专家30%+用户10%）生成动态排名。数据月度更新，申报需通过ISO认证审核，排名不分先后，仅供参考。",589]